Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • United States
Investment stages
  • Seed
  • Series A
  • Series B
  • Series C
  • Growth
Industries
  • Life Sciences
  • Biotechnology
  • Health Tech
About
Redmile Group is a global investment firm specializing in healthcare, investing across public and private markets to support companies driving advancements in biotechnology, therapeutics, and healthcare delivery.
Min check size
$1M
Max check size
$20M
Fund size
NPS

Investment Thesis

Redmile Group is a San Francisco–based healthcare investment firm specializing in early-stage, venture, private equity, and post-IPO equity investments focused on biotechnology, therapeutics, life sciences, and medical devices. Its strategy centers on identifying companies with significant growth potential in innovative R&D, frequently leading investment rounds with sizable capital deployments.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Redmile Group is a healthcare-dedicated investment firm with senior leaders drawn from long biotech and pharma careers, though specific tenure details and team backgrounds are not openly outlined on their site.

Redmile Group Contacts Information

Primary contact

Secondary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp